Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maryam Alobaidly"'
Autor:
Miranda M Monk, Ramy H Elshaboury, Nikitha R Patel, David W Kubiak, Maryam Alobaidly, Sarah P Hammond
Publikováno v:
Open Forum Infectious Diseases. 9
Background Streptococcus mitis is a common colonizer of the human oral and gastrointestinal tract. Patients with neutropenia due to hematologic malignancy (HM), particularly those prescribed fluoroquinolone prophylaxis are at increased risk of a S. m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3e581cf8b1e9e7a90b0334ba6ee3fc0
https://doi.org/10.1093/ofid/ofac492.1617
https://doi.org/10.1093/ofid/ofac492.1617
Autor:
Dariel Delos Reyes, Mary G. Amato, Diane L. Seger, Joel B. Krier, Maryam Alobaidly, Sarah Hasan, Sonam N. Shah, Roseann S. Gammal, David W. Bates
Publikováno v:
Drug Safety. 44:601-607
Medication-related harm represents a significant issue for patient safety and quality of care. One strategy to avoid preventable adverse drug events is to utilize patient-specific factors such as pharmacogenomics (PGx) to individualize therapy. We me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15d4037e197d729058723768ebd5cc7e
https://doi.org/10.1007/s40264-021-01050-6
https://doi.org/10.1007/s40264-021-01050-6
Autor:
Julie Kelly, Maryam Alobaidly, Muthiah Vaduganathan, Megan N. Rhoten, Bryan M. Cook, Lina Matta, Parth N Patel, Jonathan W. Cunningham, Thomas D Bernier, Leo F. Buckley, Danielle M. Knowles, Alea Moscone, Jillian Dempsey, Lauren Sinnenberg, Rhynn Malloy, Krishan Sharma, Catherine Ulbricht, Niteesh K. Choudhry, Mary G. Amato, Mahan Nekoui, Caroline A. Snyder, Anubodh S. Varshney, Kenneth Lupi, Clara Ting, Erin E. McElrath, Ankeet S. Bhatt, Dale Adler, Karola S. Jering
Publikováno v:
European journal of heart failureReferences. 23(7)
AIMS Implementation of guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) remains incomplete. Non-cardiovascular hospitalization may present opportunities for GDMT optimization. We assessed the efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2ee5956f533ccd00e88dcc54698a3c5
https://pubmed.ncbi.nlm.nih.gov/33932310
https://pubmed.ncbi.nlm.nih.gov/33932310
Autor:
Sonam N, Shah, Roseann S, Gammal, Mary G, Amato, Maryam, Alobaidly, Dariel Delos, Reyes, Sarah, Hasan, Diane L, Seger, Joel B, Krier, David W, Bates
Publikováno v:
Drug safety. 44(5)
Medication-related harm represents a significant issue for patient safety and quality of care. One strategy to avoid preventable adverse drug events is to utilize patient-specific factors such as pharmacogenomics (PGx) to individualize therapy.We mea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0107904bb21a1e62a4dc7cccc2b53a47
https://pubmed.ncbi.nlm.nih.gov/33620701
https://pubmed.ncbi.nlm.nih.gov/33620701
Autor:
Karola S. Jering, Lina Matta, Maryam Alobaidly, Alea Moscone, Rhynn Malloy, Ankeet S. Bhatt, Mahan Nekoui, Clara Ting, Julie Kelly, Brian Cook, Dale Adler, Jonathan W. Cunningham, Kenneth Lupi, Leo F. Buckley, Erin E. McElrath, Catherine Ulbricht, Emily Hinchey, Niteesh K. Choudhry, Danielle M. Knowles, Muthiah Vaduganathan, Jillian Dempsey, Lauren Sinnenberg, Megan N. Rhoten, Anubodh S. Varshney, Thomas D Bernier, Mary G. Amato
Publikováno v:
Journal of Cardiac Failure
Introduction Implementation of GDMT for HFrEF remains low. We assessed the feasibility of a virtual GDMT Team for optimization of GDMT during hospitalization for non-CV conditions. Hypothesis A GDMT Team will improve GDMT optimization compared with u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb33d5e4726afbe1d0a54fa2caa8c272
http://europepmc.org/articles/PMC7527179
http://europepmc.org/articles/PMC7527179